Serum free thiols predict cardiovascular events and all-cause mortality in the general population: a prospective cohort study
Open Access
- 27 May 2020
- journal article
- research article
- Published by Springer Nature in BMC Medicine
- Vol. 18 (1) , 1-12
Abstract
Background: Serum free thiols (R-SH, sulfhydryl groups) reliably reflect systemic oxidative stress. Since serum free thiols are rapidly oxidized by reactive species, systemic oxidative stress is generally associated with reduced serum free thiol levels. Free thiols associate with favorable disease outcomes in many patient cohorts, and the current hypothesis is that oxidative stress might also play an important role in cardiovascular disease. In this study, we aimed to establish the role of serum free thiols in the general population by investigating their relationship with the risk of cardiovascular (CV) events and all-cause mortality. Methods: Participants (n = 5955) of the Prevention of REnal and Vascular ENd-stage Disease (PREVEND) cohort study from the general population were included. At baseline, serum levels of free thiols were quantified and adjusted to total protein levels. Protein-adjusted serum free thiol levels were studied for their associations with clinical and biochemical parameters, as well as with the risk of CV events and all-cause mortality. Results: The mean protein-adjusted serum free thiol level was 5.05 ± 1.02 μmol/g of protein. Protein-adjusted serum free thiols significantly predicted the risk of CV events, even after adjustment for potential confounding factors (hazard ratio [HR] per doubling 0.68 [95% confidence interval [CI] 0.47–1.00], P = 0.048). Similarly, protein-adjusted serum free thiols were significantly predictive of the risk of all-cause mortality (HR per doubling 0.66 [95% CI 0.44–1.00], P = 0.050). Stratified analyses revealed lower HRs for subjects with a lower body mass index (BMI), without hypertension, and without diabetes. Conversely, HRs were lower in subjects with albuminuria. Conclusions: In this large population-based cohort study, serum free thiols significantly predicted the risk of CV events and all-cause mortality. Our results highlight the potential significance and clinical applicability of serum free thiols since they are amendable to therapeutic intervention.Keywords
Funding Information
- Dutch Kidney Foundation (E.013)
This publication has 43 references indexed in Scilit:
- Crohn’s Disease in Clinical Remission Is Marked by Systemic Oxidative StressFrontiers in Physiology, 2019
- Rapid free thiol rebound is a physiological response following cold‐induced vasoconstriction in healthy humans, primary Raynaud and systemic sclerosisPhysiological Reports, 2019
- Oxidative stress, aging, and diseasesClinical Interventions in Aging, 2018
- CVD and Oxidative StressJournal of Clinical Medicine, 2017
- Socio-economic status in relation to smoking: The role of (expected and desired) social support and quitter identitySocial Science & Medicine, 2016
- A novel oxidative stress marker in acute myocardial infarction; thiol/disulphide homeostasisThe American Journal of Emergency Medicine, 2015
- Serum thiols and cardiovascular risk scores: a combined assessment of transsulfuration pathway components and substrate/product ratiosJournal of Translational Medicine, 2013
- Predicting the 30-Year Risk of Cardiovascular DiseaseCirculation, 2009
- Reduced Level of Serum Thiols in Patients with a Diagnosis of Active DiseaseJournal of Anti-Aging Medicine, 2003
- Thiol-based antioxidants2001